Menu
GeneBe

CARMIL2

capping protein regulator and myosin 1 linker 2

Basic information

Region (hg38): 16:67644987-67657569

Previous symbols: [ "RLTPR" ]

Links

ENSG00000159753NCBI:146206OMIM:610859HGNC:27089Uniprot:Q6F5E8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • severe combined immunodeficiency due to CARMIL2 deficiency (Moderate), mode of inheritance: AR
  • severe combined immunodeficiency due to CARMIL2 deficiency (Strong), mode of inheritance: AR
  • severe combined immunodeficiency due to CARMIL2 deficiency (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Immunodeficiency 58ARAllergy/Immunology/Infectious; OncologicIndividuals may have severe and frequent infections, and prophylactic measures, as well as early and aggressive treatment of infections may be beneficial; Individuals may be at increased risk of certain types of neoplasms, and awareness may allow prompt diagnosis and managementAllergy/Immunology/Infectious; Dermatologic; Oncologic; Pulmonary27647349; 27896283; 28112205; 29479355

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CARMIL2 gene.

  • not provided (746 variants)
  • Severe combined immunodeficiency due to CARMIL2 deficiency (29 variants)
  • Inborn genetic diseases (11 variants)
  • CARMIL2-related condition (9 variants)
  • not specified (8 variants)
  • Combined immunodeficiency;Chronic colitis (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CARMIL2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
176
clinvar
7
clinvar
188
missense
1
clinvar
3
clinvar
335
clinvar
11
clinvar
9
clinvar
359
nonsense
10
clinvar
3
clinvar
1
clinvar
14
start loss
0
frameshift
10
clinvar
4
clinvar
1
clinvar
15
inframe indel
5
clinvar
1
clinvar
6
splice donor/acceptor (+/-2bp)
9
clinvar
1
clinvar
10
splice region
22
29
3
54
non coding
5
clinvar
102
clinvar
23
clinvar
130
Total 21 19 352 289 41

Highest pathogenic variant AF is 0.0000461

Variants in CARMIL2

This is a list of pathogenic ClinVar variants found in the CARMIL2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-67645252-C-T Likely benign (Dec 01, 2022)2879138
16-67645256-A-C Inborn genetic diseases Uncertain significance (Aug 13, 2021)2244748
16-67645261-C-G Likely benign (Jul 11, 2022)1532619
16-67645261-C-T Likely benign (Nov 22, 2023)1647926
16-67645262-G-A Uncertain significance (Mar 12, 2022)1901141
16-67645264-C-A Uncertain significance (Aug 20, 2022)1958671
16-67645264-C-T Likely benign (Jan 09, 2023)2777780
16-67645274-T-G Uncertain significance (Jun 20, 2022)1398343
16-67645280-C-T Uncertain significance (Aug 10, 2022)2079064
16-67645281-T-C Uncertain significance (Feb 01, 2022)1675628
16-67645283-C-T Pathogenic (Feb 10, 2022)1388986
16-67645298-C-G Likely benign (Dec 27, 2023)1642555
16-67645299-C-T Likely benign (Jan 06, 2024)2704298
16-67645303-C-T Likely benign (Feb 22, 2023)2982098
16-67645445-C-T not specified Benign (Jan 24, 2024)2688465
16-67645535-C-G Uncertain significance (Apr 16, 2022)1470895
16-67645541-C-T Uncertain significance (Nov 02, 2022)1396051
16-67645553-G-A Likely benign (Apr 04, 2023)2712585
16-67645592-C-T Likely benign (Jun 01, 2022)1694800
16-67645596-C-T Likely benign (May 04, 2022)2133866
16-67645602-G-C Uncertain significance (Aug 21, 2022)1941826
16-67645604-G-A Likely benign (Jan 25, 2024)1570094
16-67645607-G-C Uncertain significance (Oct 13, 2023)3018222
16-67645614-G-A Uncertain significance (Feb 22, 2022)1913392
16-67645621-A-G Uncertain significance (Feb 21, 2023)2185220

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CARMIL2protein_codingprotein_codingENST00000334583 3812651
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.93e-111.001249710561250270.000224
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.577038310.8460.00005229032
Missense in Polyphen179236.340.75742931
Synonymous0.7743463650.9480.00002423095
Loss of Function4.813277.80.4110.00000445803

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006450.000600
Ashkenazi Jewish0.00009960.0000993
East Asian0.0002940.000274
Finnish0.00009290.0000926
European (Non-Finnish)0.0002860.000256
Middle Eastern0.0002940.000274
South Asian0.0002360.000229
Other0.0001720.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Cell membrane-cytoskeleton-associated protein that plays a role in the regulation of actin polymerization at the barbed end of actin filaments. Prevents F-actin heterodimeric capping protein (CP) activity at the leading edges of migrating cells, and hence generates uncapped barbed ends and enhances actin polymerization (PubMed:26466680). Plays a role in cell protrusion formations; involved in cell polarity, lamellipodial assembly, membrane ruffling and macropinosome formations (PubMed:19846667, PubMed:26578515, PubMed:26466680). Involved as well in cell migration and invadopodia formation during wound healing (PubMed:19846667, PubMed:26578515, PubMed:26466680). {ECO:0000269|PubMed:19846667, ECO:0000269|PubMed:26466680, ECO:0000269|PubMed:26578515}.;

Recessive Scores

pRec
0.0922

Intolerance Scores

loftool
rvis_EVS
-1.12
rvis_percentile_EVS
6.61

Haploinsufficiency Scores

pHI
0.228
hipred
N
hipred_score
0.429
ghis
0.614

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Mouse Genome Informatics

Gene name
Carmil2
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; pigmentation phenotype; vision/eye phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
establishment or maintenance of cell polarity;positive regulation of lamellipodium assembly;maintenance of cell polarity;positive regulation of cell migration;wound healing, spreading of cells;actin filament network formation;establishment or maintenance of monopolar cell polarity;positive regulation of extracellular matrix disassembly;positive regulation of ruffle assembly;positive regulation of lamellipodium organization;negative regulation of barbed-end actin filament capping
Cellular component
ruffle;cytoplasm;plasma membrane;actin cytoskeleton;membrane;lamellipodium;extrinsic component of cytoplasmic side of plasma membrane;cell leading edge;macropinosome;intermediate filament cytoskeleton
Molecular function
phospholipid binding;protein-containing complex binding